San Diego businessman and philanthropist Arthur Brody has pledged $1 million to Sanford-Burnham Medical Research Institute to help accelerate the Institute’s ability to translate basic science discoveries into new treatments.
Brody, a longtime Sanford-Burnham trustee, is the president of Brosoar Corp., an investment company based in Rancho Santa Fe.
The gift creates the Art Brody Innovation Fund, which will advance promising research that might otherwise be stalled due to lack of financial support. The fund will be used, in part, to refine early drug candidates being developed at the Conrad Prebys Center for Chemical Genomics, and to bring in investors and advance new medicines into clinical trials.
The Innovation Fund will also provide seed capital for companies that have been spun-out to commercialize Sanford-Burnham discoveries.
“Bridging the gap between the laboratory bench and the patient’s bedside is a critical component of our mission,” said John Reed, M.D., Ph.D., CEO, professor and Donald Bren Chief Executive Chair.
The research institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies. It has operations in California and Florida/ For more information, visit